| Name | N-(1-Benzyl-2,3-dihydro-1H-pyrrolo[2,3-b]quinolin-4-yl)-2-phenyla cetamide |
|---|
| Description | PGP-4008 is a specific P-glycoprotein (Pgp) inhibitor. PGP-4008 inhibits tumor growth in a murine syngeneic Pgp-mediated multiple drug resistance (MDR) solid tumor model when given in combination with Doxorubicin[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C26H23N3O |
|---|---|
| Molecular Weight | 393.48000 |
| Exact Mass | 393.18400 |
| PSA | 48.72000 |
| LogP | 5.69320 |